ATS Corporation Q1 2027 Earnings Recap

ATS shares plunged 24.9% on disappointing top-line execution and margin pressure amid weaker-than-expected revenue and a cautious near-term outlook. The company’s 5% revenue decline, stemming from a lower order backlog and reduced large-scale automotive projects, and a 13% drop in adjusted operating earnings failed to reassure investors.

Key Takeaways

• Adjusted revenues declined 5% year-over-year due to lower opening backlog, timing of project execution, and intentional pullback in large automotive work.
• Adjusted earnings from operations fell 13% to $68 million, reflecting the impact of a smaller revenue base on profitability.
• Order backlog stands at approximately $1.9 billion, with strength in life sciences—particularly radiopharma—partially offset by softness elsewhere.
• Fixed cost transformation program underway, aiming for $20 million in annualized savings from European operations as part of an 18-month efficiency drive.
• Management emphasized long-term margin expansion and growth opportunities, but near-term execution challenges and ongoing restructuring tempered confidence.